Enhancement of apomorphine-induced climbing in mice by reversible and irreversible narcotic antagonist drugs.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D004357:Drug Synergism; D008297:Male; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D013997:Time Factors
D009292:Narcotic Antagonists; D009588:Nitrogen Mustard Compounds; D009270:Naloxone; D009271:Naltrexone; C017120:chlornaltrexamine; D001058:Apomorphine